Kodiak Sciences (KOD) Return on Capital Employed Growth (1y) (2019 - 2026)

Kodiak Sciences (KOD) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1,648.00
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 31,429.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1,805.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 2,503.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -105.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -3,457.00
10 Kodiak Sciences 2.62 Bn 2.62 Bn - -1,429.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,429.00
Dec 31, 2025 -4,109.00
Sep 30, 2025 -5,824.00
Jun 30, 2025 -3,082.00
Mar 31, 2025 -1,236.00
Dec 31, 2024 191.00
Sep 30, 2024 165.00
Jun 30, 2024 450.00
Mar 31, 2024 -277.00
Dec 31, 2023 -567.00
Sep 30, 2023 -542.00
Jun 30, 2023 -1,119.00
Mar 31, 2023 -1,579.00
Dec 31, 2022 -2,229.00
Sep 30, 2022 -2,851.00
Jun 30, 2022 -2,719.00
Mar 31, 2022 -2,314.00
Dec 31, 2021 -1,250.00
Sep 30, 2021 44.00
Jun 30, 2021 0.00